Canadian Securities ExchangeThe Daily Bell

Alex Halperin on the State of the Cannabis Market in the US

February 23, 2022

About This Video

CSE's Barrington Miller is joined by Alex Halperin, Editor of WeedWeek, to discuss the cannabis industry in the United States, with a particular focus on the markets in California, New York, and the southern states. The conversation also dives into the dynamic of politics in US federal legalization, WeedWeek's 2022 outlook, and the potential role of Big Pharma in the sector.

Here's an overview of what Barrington and Alex discuss in this edition of the "Exchange for Entrepreneurs" podcast:

00:00 - Introduction and background

04:30 - Cannabis culture in California

07:30 - The challenge of running a cannabis business in California

11:00 - New York's cannabis market

13:30 - Oklahoma's cannabis market

17:30 - Texas' cannabis market

19:10 - Cannabis legalization in Washington

22:20 - WeedWeek's outlook on 2022

25:10 - What is Delta-8?

28:50 - Big Pharma's involvement in the cannabis market

Subscribe for more great CSE insights and interviews here: https://go.thecse.com/CSETV-Subscribe

STAY CONNECTED WITH THE CSE

=============================

- PODCAST: https://blog.thecse.com/cse-podcasts/

- INSTAGRAM: https://www.instagram.com/canadianexchange/

- LINKEDIN: https://ca.linkedin.com/company/canadian-securities-exchange

- FACEBOOK: https://www.facebook.com/CanadianSecuritiesExchange/

- TWITTER: https://twitter.com/CSE_News

- BLOG: https://blog.thecse.com/

- WEBSITE: https://thecse.com/

- MAGAZINE: https://issuu.com/thecse/docs

Read the TranscriptAuto-generated by YouTube; names and terms may be misspelled.

hi my name is barrington miller director of issuer engagement at the canadian securities exchange and today i'm here with alex halperin he is weed week a freelance business journalist that covers the cannabis industry and everything surrounding it alex thank you for agreeing to come on to this amendment of a of a podcast for the cannabis investor series thanks so much for having me great to be here so where where in the

world are you right now i'm in los angeles and how how's everybody doing how's the world around you well it's you know it things are easier in l.a when when it's 70 degrees and sunny as it is right now so certainly you know we we've had our share of hardships like everybody else but the weather helps and it still does and it seems like the the latest

wave of viruses waning so we're all pretty excited about that now for those of you who are new to new to this podcast or or new to the industry or anything like that you may have heard of a publication called weed week well you are looking at weed week and alex can you tell us how you started it and why you chose to get into

it sure basically your journey how did you get here so i was a business reporter in in new york and and cannabis wasn't a part of my life and a little more than seven years ago fast company magazine sent me to las vegas to cover what that is now was the sort of world's largest cannabis trade show mj bizcon and i got there and i thought wow this

is this is an amazing story that that nobody is covering and and i should cover it and not too long after that i moved to denver which then is now which then was the sort of center of the the american cannabis industry and i started covering it for a various variety of publications and i started writing a newsletter weed week because the the things that were happening in

the industry were happening all over the place they were in in states in in washington dc and then they were in on farms in in boardrooms on stock exchanges and it seemed that there would be some value in in a resource that sort of gave folks an idea of everything they need to know that that happened this week and i think that hopefully is is still why

why people read it because we we bring together sort of the most important and interesting events in the industry in the last few days and this apply and now we we really focus on writing it for people in the industry and the news that is most relevant for them and right now we're pretty focused on on the us market although we certainly address certain issues and and certain companies

within the canadian market as well if you like i couldn't agree more that the the us i believe is the place that should be the focus i think if you're looking for investment opportunities and i do not espouse to give investment investment advice all of those things but the the us you you can't overlook it you know you have canada and then you have the population of

california which is one in the same so that that should be able to tell you something michigan has 300 000 medical patients canada has 300 000 medical patients it's it's not even it's not even the same sport but you did touch upon california and california is i guess where everybody looks to at least on the west coast as far as what's going on and what what's happening can you can

you tell us what is going on there right now sure so so california in terms of cannabis culture is certainly sort of the there there are various nodes of cannabis culture across the country but but california certainly has a has a very special place in that and it's also the the biggest market and also a a market with global influence so that the idea of people here hope that

once there's an international industry that people will feel it feel an affinity for californian cannabis much in the way they they feel an affinity for for french wine or italian wine or something like that and and the culture ranges from the tens of thousands of growers who operated in the illegal market and are now to various degrees being integrated or not into the the ill into the legal market as well as

all sorts of music the silicon valley has a rich history of cannabis use and influence so so there there are all sorts of different things there but i mean right now there's a lot of focus on the structure of california's industry so right now taxes are very high the the illegal market is still a major force it it's said to be twice as large as california's market

which is the largest and california is the largest market in the u.s at about four to five billion dollars a year so that's probably bigger than the canadian market i i would imagine yeah i would imagine that as well but and don't forget that's us dollars yes u.s dollars so so california's market is huge but the way it's structured with regards to taxes and regulations for exa it it's

a very hard market to to survive in and a lot of businesses especially a lot of the smaller businesses are are struggling and there's sort of a protest movement going on right now to to save craft farmers many of whom had a place in the legacy market to support black and brown owned businesses of course these are the communities that bore the worst of the war on drugs

and are now there aren't too many success stories of black and brown-owned businesses surviving in the legal industry both in california and in other states so so it's this incredibly rich place for for cannabis culture and cannabis business but it's a very hard place to run a business and that's one of the reasons why a lot of the the multi-state operators were the the big u.s companies the the

biggest u.s companies many of the ones that are publicly trading on in canada i i believe on on your exchange although maybe there's more than one exchange i'm not an expert on that a lot of those companies don't really have much of a presence in in california they are much more focused on smaller life smaller markets where cannabis is a bit of a bit more of a

foreign entity both to consumers and regulators and so some folks would say they're growing mediocre product i i'm not gonna weigh in on that i haven't had enough of their products but but i would say that what the the market conditions that they prefer or that they tend to thrive in which include states that limit the number of licenses so that essentially the biggest companies are only are the only game in town like

those business models have not yet thrived in in california and there's fear among those concerned about the current state of the market that those businesses will arrive in california sort of buy up all the struggling companies and it will be a very quote-unquote corporate cannabis market and that's sort of an ambiguous term because every everybody involved is a company but corporate implies scale and a certain perhaps a

blandness of culture and and things along those lines there's more concern for the bottom line versus the patient versus the end user versus all of those and it's just the push to push the push let's grow and get bigger and take more market share you know what those those are all valid points and very very true and you know what i've interviewed a lot of people

and i can honestly say i don't think anybody has touched upon you know california is is hard like it's it's a hard place to to cut your teeth and to to grow and you see it with a lot of the the multi-state operators many of whom are listed in trading on the canadian securities exchange which you can find at www.thecsc.com now there's there's the emergence of

the northeast market you have new york new york state new jersey massachusetts pennsylvania and this isn't an east coast west coast thing but there is a thing in that thing being there is a difference and new york is i think trying to position itself as being the the cultural mecca of of of cannabis whether it's in the united states or just like california wants to get its brand

globally new york was is vying for the same thing yeah let's let's talk a little bit about what's going on in the in the northeast and how how that's shaping the industry so i'm i'm from new york and so they legalized just short of a year ago i believe through the the legislature and now former governor cuomo who had to step down really pushed for it and it may have been sort of a

way to distract from some of his his various other issues going on but new york is obviously a huge market and it the as the sort of media headquarters of the of the country or the world as as plenty of new yorkers will tell you that certainly gives gives cannabis a a global presence that whereas california's cultural cachet comes perhaps through movies and tv shows

so this is going to be a huge market but but it but probably a market much more like the sort of more corporate markets that that i was talking about earlier they're certainly going to be efforts to support equity businesses but and and perhaps some of them will will thrive but but ultimately you got to think that big companies are going to have a big

portion of the market probably the best way to to look at that are in states like illinois and florida where the markets are already quite a bit larger than in new york and new jersey and the rules intensely favor the big companies and states can do it in in different ways but but ultimately the big companies like states that limit the number of licenses limit the competition and

essentially enable companies to build market share just for showing up and there's definitely going to be some of that in new york as the market opens over the next sometime between i would say 12 and 24 months from now also similarly in new jersey and connecticut i think you're going to have a similar situation what about the middle of the united states like you mentioned illinois but

going right down the middle all the way down through texas and and you know the south yeah what's what's gonna like i think the south is gonna mimic a lot of what florida is doing because florida keeps getting left out of the southern diatribe for whatever reason but i think they're going to just go okay and that'll bleed over into the southern states but the like middle

america and are they gonna borrow from from illinois i know missouri missouri is tired of those tax dollars going along up the river and and so i'm really curious as to i don't want to call it battlegrounds but what will happen in that part of the united states sure so i mean what's interesting is that i mean we live in a very polarized nation right now

but legalization is about as close to bipartisan as as an issue can can be so one of the booming markets right now is oklahoma and they have a very sort of they oklahoma certainly has a bible belt aspect but its conservatism also dates back to the the oil industry and the sort of very freewheeling low regulation laissez-faire market and that's what you have going on in in

oklahoma where it turns out that very conservative you know there's a song we don't smoke marijuana in muskogee but it turns out that not only do they smoke marijuana in muskogee but they're now you know a dozen or so dispensaries where you can replenish your stash and because it's said to be as easy to open a taco a dispensary in oklahoma as it is to open a taco stand and whereas in

florida i don't even know if they're giving away any more licenses but to apply for one or to buy if you were to try and buy an existing license in florida that would cost you tens of millions if not hundreds of millions of dollars whereas in oklahoma they have thousands they have well over a thousand dispensaries for pretty small state population so i i think when you when you look at

sort of the the middle of the country you can see sort of states weighing that kind of spectrum that sort of social conservatism mississippi just legalized on a medical on a with a very strict program or a relatively strict program oklahoma is also a medical program but it's much more free freewheeling much more business-friendly which is to say much more consumer-friendly as well and so so if you sort of

take a triangle formed by oklahoma mississippi and then illinois with its sort of chicago the which was described to me as the the state market was described to me as a state-mandated oligopoly and and i think in in a lot of these other states you're going to see them sort of navigating between these different polls no that's a that's an excellent point and i think that song that you're

referring to i actually believe the guy sang it at one of the presidential inaugurations or something and got it could have been could have been nixon or somebody in that era it could be because they wanted they wanted the vote and yeah the place erupted and went crazy but yeah but i but i digress no that's those are those are really really good

points texas what's texas is another country it's its own its own beast and what is going on there so texas like anywhere else cannabis has the potential to do very well there and i i think oklahoma shows that at the same time just passing things in texas is very hard and especially something where there there is still a fair amount of conservative opposition it's very hard to

make something like that happen but i think it it will happen sooner sooner or later but again and i believe so in texas it's very hard to do a ballot initiative which is how legalization has happened in a lot of states and the legislature only meets every two years so so it becomes very very hard to to get things done let's we've been dancing we've been

tiptoeing around the topic of politics republican democratic and i i think when they when the current administration was was running there was a lot more a lot more hope that was going to happen as far as the legalization discussion and since they've been in office that's that's been waning and i think the delay is going to be pushed even further personally but what's your what's your take on on

what's going on in washington so president biden is an outlier among democrats in that he doesn't support legalization but he did make some campaign promises that folks in the industry are pretty disappointed with he said he would i believe expunge a certain num all non-violent i don't know all but free a certain number of federal cannabis prisoners hasn't happened and and other aspects where

oh a lot of people in the industry are are questioning his commitment to even the the promises he made at the same time the republicans are getting you know as we discussed you know mississippi just legalized oklahoma has legalized bigger these are some of the reddest states in the country and republicans are beginning to pick up on this the the latest representative nancy mace of south carolina has

proposed a legalization bill that she says needs bipartisan support i think the industry would be pretty happy with with her bill and so a wall street analyst the other day called it the only game in town right now there are there's another push right now to not quite legalize but enable companies to have access to the financial system and that hasn't there's always there have been numerous

attempts to make that pass but it took to get that through congress but it hasn't happened yet there's another attempt right now but ultimately i i think we're going to see the industry shift get cozier with republicans for the same for similar reasons to the reason a lot of industries are cozier with republicans they figure favor lower taxes and and fewer regulations and at the same time

i think republicans are letting down their guard about some of the problems they had with cannabis so right i think they're gonna become closer friends i think it boils down to to a certain extent money and the amount the amount of volume of money that is being generated the amount of tax revenue per state i know colorado back in the early days they paid more

than our four biggest banks in canada in taxes alone like it's it's it's insane and you know what that gets people's attention that really does now what is your what is your 2022 outlook as far as the the landscape you're looking into weed week's crystal ball of 52 weeks and what do you see what do you see happening this year as we as we sort of emerge out of

the pandemic and i'm knocking on wood that yeah yeah i i don't know enough to to predict what's gonna happen in in congress i i'm not a close enough watcher and people i know and respect have have contradictory opinions but we we can definitely expect more people to have access to cannabis in in more states so new jersey is likely to open this year new york and connecticut

could open this year and then you have more states that are going to could likely legalize recreational those include missouri arkansas ohio which would be very big pennsylvania and so so this the industry and the the industry's footprint and access is going to increase no matter what happens in washington even as the plants sort of legal position becomes increasingly untenable i think one thing to look out for and i don't

quite know if it's going to happen this year or not but for for a long time the only cannabinoids with any sort of market are our thc which is of course gets people high and and cbd which has sort of properties similar to a nutraceutical as well as pharmaceutical properties it's been approved as a drug for certain very severe epilepsy disorders the cannabis plant produces scores of different

more cannabinoids and we're beginning to see those in products in california and probably to a much lesser extent in in other markets i think there's one called cbn that is said to promote sleep the extent and all the cbd is very little studied these new products are even less studied and so what they do we're like some are said to increase appetite or suppress appetite

provide energy or different kinds of highs this is all largely based now on anecdotal evidence and it's probably going to remain anecdotal evidence for the foreseeable future but at the same time companies are going to be talking a lot more about these sort of functional products and to the extent that they work as advertised that's probably going to be in in the mind of the the consumer

and we're all basically relying on the fact that cannabis is seems to be well tolerated in the overwhelming number of people who take it so that it's not really a safety issue but there are potential for for safety issues so for example this year a product called delta eight became i'm so good i'm so glad you brought that up because that's a perfect segue that was literally my next my next question

to talk about delta eight okay great so so for for listeners who don't know delta eight is a chemical thc is known as officially delta nine tetrahydrocannabinol i believe that that may not quite be right anyway delta eight is a slight variation on it that because it's not explicitly banned or because it due to a legal loophole it's been available in head shops and gas stations

and a variety of businesses in states where cannabis isn't legal but unlike cbd it gets people high but but the thing about delta 8 is that so that has created a whole huge loophole and all sorts of controversy and confusion in in various state markets and some of which have banned it some of it require that it go through the same regulatory process as cannabis but safety is a bit more of an issue

with delta eight assuming that and thus far i'm not aware of anything that contradicts this assuming that the products made by the plant are going to be well tolerated by people and not cause enormous crises delta eight is actually a manufactured product it's manufact it's manufactured by applying certain kinds of solvents to cbd so that introduces the potential for harm or for for dangerous products to be introduced especially in an unregulated

market which the delta eight market is so that creates potential for confusion and harm and it will be interesting to see and so a lot of states are sort of not allowing it but it it adds a whole new layer of complications to the legalization process it's like are all cannabis products legal and then are all chemicals found in the plant legal and are all the plants that are derived from

products found in the plant illegal so at any time so there is the potential for delta eight products to harm people to to in ways that we're not really familiar with legal cannabis products harming people and that of course adds all sorts of complications speaking of complications and synthetic mixing and concocting this segues into my last topic which is big pharma big pharma and cannabis for they seem diametrically opposed

one has a fear of the other the other one wants the other one has where is big pharma headed in this i mean i know they're around i know they're already involved but yeah where where are they at right now yeah so well it was a pharmaceutical company based in the uk called gw pharmaceuticals that developed the cbd drug epidiox which is has been approved by

the american food and drug administration to treat certain very severe kinds of childhood epilepsy now that company has been acquired by a bigger company called jazz pharmaceuticals which is based in ireland which is interested presumably both in the existing drug but also in other medical applications for cbd and and other cannabinoids found in the plant so big pharma is is definitely around pfizer a company called arena that

i believe is developing various cannabinoid products i'm not 100 sure on that and and this is definitely a way that big pharma is going to get interested in the industry so that for example the canadian company canopy growth which is one of the the largest canadian companies i believe sued gw pharmaceuticals with some with regards to some of its intellectual property i don't know the the details of of that

case but the point is big pharma is around there's you hear a lot of fears in the community of sort of big pharma taking over what's now considered like the recreational cannabis industry my instinct is to think that those fears are probably overblown big pharma has an expertise in developing and running trials on pharmaceuticals which is an incredibly time and resource intensive process and if they're interested in

cannabinoids which it seems pretty clear that at least some of them are they probably want to run it through that process because that's where they have that's how they know how to run a business that's how they know how to make money and create a moat around what they're doing could it's not out of the realm of possibility that they would want to start selling cannabis over the counter but

my instinct is to think that pfizer acquiring the msos the existing big companies which are still much smaller much much smaller than a company like pfizer i think those those tend to be overblown i if anything i i would think that an alcohol or a tobacco company we can already see the traces of it but they are much more likely to move into

the sort of consumer over-the-counter recreational segment yeah i think big pharma will move slow i think they will be patient they will let's see how this thing this industry shakes out let's let's wait and see like really wait i'm you know fi big farmer isn't getting into it fully into it anytime soon that's that's what i think it's plug time alex tell people where they can find you

how to subscribe to weed week and all of those good things yeah well thanks so much so yeah you can subscribe to the the free weed week newsletter at weedweek.com we also have a job board in case you're looking for excellent candidates to to work for your company i always say that weed week readers make the best colleagues so check that out as well and

we will see you at weed week oh that's awesome and our listeners and our audience we are going to make sure that alex comes back for our cannabis investor series which will be coming this spring 2022 and on that note alex on behalf of the canadian securities exchange i just want to say thank you for sharing your thoughts your insights your wisdom and your observations

regarding the cannabis industry and you know stay safe and we really really appreciate it can't wait to can't wait we can meet in person indeed thanks so much it's been a lot of fun no this is great i'm your host barry miller this has been an episode part of the cannabis investor series thank you and we'll see you on the next show

you